[sci.med] HICN233 News Part 1/2

ATW1H%ASUACAD.BITNET@oac.ucla.edu (Dr David Dodell) (09/12/89)

--- begin part 1 of 2 cut here ---
Volume  2, Number 33                                      September 11, 1989

              +------------------------------------------------+
              !                                                !
              !              Health Info-Com Network           !
              !                    Newsletter                  !
              +------------------------------------------------+
                         Editor: David Dodell, D.M.D.
                   St. Joseph's Hospital and Medical Center
    10250 North 92nd Street, Suite 210, Scottsdale, Arizona 85258-4599 USA
                           Telephone (602) 860-1121

     (c) 1989 - Distribution on Commercial/Pay Systems Prohibited without
                              Prior Authorization

             International Distribution Coordinator: Robert Klotz
                            Nova Research Institute
            217 South Flood Street, Norman, Oklahoma 73069-5462 USA
                           Telephone (405) 366-3898

The Health Info-Com Network Newsletter is distributed weekly.  Articles  on  a
medical  nature  are  welcomed.  If  you  have an article,  please contact the
editor for information on how to submit it.  If you are intrested  in  joining
the distribution system please contact the distribution coordinator.

E-Mail Address:
                                    Editor:
                              FidoNet = 1:114/15
                           Bitnet = ATW1H @ ASUACAD
                     Internet = ddodell@stjhmc.fidonet.org
                         LISTSERV = MEDNEWS @ ASUACAD
                         anonymous ftp = vm1.nodak.edu
       (Notification List/ftp = hicn-notify-request@stjhmc.fidonet.org)

                                 Distribution:

North America                               Australia/Far East    Europe
FidoNet = 1:19/9                            David More            Henk Wevers
Usenet  = krobt@mom.uucp                    FidoNet = 3:711/413   Fidonet
Internet = krobt%mom@uokmax.ecn.uoknor.edu                        2:500/1

                                   Sponsors
                                   ========
   Dr. Edward Delgrosso Black Bag BBS (FidoNet 1:150/101) Tel 1-302-731-1998

===============================================================================

                       T A B L E   O F   C O N T E N T S

1.  Medical News
     Medical News for Week Ending September 11, 1989 .......................  1

2.  Center for Disease Control Reports
     [MMWR 9-7-89]   Measles - United States, 1988 .........................  5
     Surgeon General's - Recommendations of Medication Working Group .......  8
     Cadmium/Lead Exposure with Pharmaceuticals Imported from Asia ......... 11
     Publication of Guide for Developing Policies for HIV-Infected Students  14

3.  Dental News
     ADA Voices Concern Over "Whitening" Toothpastes ....................... 15

4.  Articles
     Heart Transplants Increase 10 Times, But Lack of Donors Persists ...... 16
     Tissue Transplants Increase Despite Screen for Infectious Agents ...... 18

Health InfoCom Network News                                           Page    i
Volume  2, Number 33                                      September 11, 1989

===============================================================================
                                 Medical News
===============================================================================

                Medical News for Week Ending September 11, 1989
        Copyright 1989 - USA TODAY/Gannett National Information Network
                          Reproduced with Permission

                                      ---
                                 Sept. 5, 1989
                                      ---

                       SEARCH WIDENS FOR MEDICAL CURES:

   The next breakthrough for treating AIDS or cancer might come from  a  tuber
that  grows  in  an  African  rain  forest  or  an exotic chemical excreted by
starfish in the South Pacific.  To find new  drugs  for  these  diseases,  the
National Cancer Institute has begun screening thousands of plants, marine life
and  microorganisms for their life-saving potential.  (From the USA TODAY Life
section.)

                           CHECKUPS A MUST FOR KIDS:

   Parents are encouraged to make speech, language and hearing checkups a part
of back-to-school preparation for children, says the American Speech-Language-
Hearing Association. The organization recommends early detection and treatment
of these disorders to reduce their impact on a  child's  social  and  academic
development.

                        TREATMENT ENDS VARICOSE VEINS:

   Virtually  all  spider  veins  and  smaller  varicose  veins can be removed
quickly and without pain by a non-surgical technique called sclerotherapy. The
procedure involves injecting saline or  sodium  tetradecyl  sulfate  into  the
vein, causing the vein to collapse and eventually dissolve, says an article in
the September issue of Prevention.

                       FUTURE OF SKIN DAMAGE CONTINUES:

   Melanoma,  a deadly form of skin cancer,  could become the most common form
of cancer in the world by the year 2000, predict experts from the Presbyterian
Medical  Center  in  Philadelphia.   Those  at  risk:   fair-skinned   people;
individuals  with moles.  Large,  irregular shaped and colored moles should be
screened twice a year for changes in development.

                        SELF-HELP BOOKS REALLY DO HELP:

   Some self-help books really do help.  A new study by a psychologist at  the
University  of  Alabama  reveals  that  reading  a  self-help  book  can be as
effective as consulting a  psychotherapist.  Two-thirds  of  mildly  depressed
adults  participating  in a study at the school showed significant improvement
after reading a book on ways to overcome depression.

                           PSYLLIUM - FOOD OR DRUG:

Health InfoCom Network News                                             Page  1
Volume  2, Number 33                                      September 11, 1989

   The Kellogg Co.'s new oat-based cereal, Heartwise, contains psyllium, which
is supposed to reduce cholesterol. Thus the question: Is psyllium a food, or a
drug.  Also,  how far can food companies go in making health claims for  their
products? The FDA is monitoring the issue.

                           HONEY SWEETER THAN SUGAR:

   Honey  is  growing  in popularity among health-conscious consumers and food
manufacturers.  Honey is 33 percent sweeter than granulated sugar and contains
fewer  calories  for  its sweetening power,  said an executive of the National
Honey Board.

                                      ---
                                 Sept. 6, 1989
                                      ---

                        MID-AGE WOMEN NOT AT HIGH RISK:

   Millions of middle-aged women who used birth control pills in their mid-20s
or later aren't at unusually high risk for breast cancer,  a major  new  study
shows.  But  the Harvard Medical School study - the largest yet,  with 100,000
women followed for 10 years - offers no reassurance for pill users  now  under
age 40. (From the USA TODAY Life section.)

                         CONSUMERS BACK GENERIC DRUGS:

   Despite  the  recent  charges  of  fraud  and mismanagement,  consumers are
standing by the generic drug industry.  Pharmacists report that customers  are
asking  questions  about  the drugs they're getting,  but few are switching to
brandname products.

                           ANTI-AIDS DRUG IN ALGAE:

   Researchers at the  National  Cancer  Institute  in  Frederick,  Md.,  have
discovered  a  substance  in  blue-green  algae  from  Hawaii  with  anti-AIDS
activity.  The finding was reported recently in the Journal  of  the  National
Cancer institute.

                         TREAT CHILD, NOT THERMOMETER:

   A  Johns  Hopkins  Children's  Center study of 68 children with chicken pox
showed that while the drug acetaminophen reduces fever,  it  may  prolong  the
illness.  Some  pediatricians  are now advising parents to withhold the fever-
reducing medicine,  if the child is comfortable,  so  that  recovery  will  be
faster.

                        COMPOUND FOR CANCER TREATMENT:

   Ondansetron,   a   compound  known  as  serotonin  antagonists,   is  under
investigation as an agent that shows promise for the treatment of  nausea  and
vomiting, associated with chemotherapy used to treat cancer patients. Research
results  were  presented  Tuesday  during  the  Fifth  European  Conference on
Clinical Oncology in London.

                         HEPATITIS B VACCINE IMPROVED:

Health InfoCom Network News                                             Page  2
Volume  2, Number 33                                      September 11, 1989

   Clinical testing of an improved hepatitis B vaccine is  expected  to  begin
within a few months, reports the Weizmann Institute of Science.  The institute
said the product would be inexpensive and might help lower  the  incidence  of
liver cancer in those who've suffered from acute hepatitis B.

                                      ---
                               Sept. 8-10, 1989
                                      ---

                         MEASLES CASES AT RECORD HIGH:

   The measles epidemic of 1989 threatens to make this the  biggest  year  for
the  disease  in  the  1980s,  the  federal  Centers for Disease Control says.
Measles cases through Aug.  28 total  9,650.  That  total  could  surpass  the
previous  high:  13,506  cases  in 1980,  says CDC epidemiologist Dr.  William
Atkinson. (From the USA TODAY Life section.)

                         COMPANY EXPANDS TRIAL SITES:

   Trimedyne Inc.  said Thursday it has received approval from the  U.S.  Food
and  Drug  Administration  to  set  up four additional coronary clinical trial
sites.  Laserwire, Lasercoil and Lasercath devices,  which use laser energy to
vaporize plaque (fatty deposits) inside blood vessels, will be tested at these
sites.

                         RICE BRAN FIGHTS CHOLESTEROL:

   Rice  bran,  found in brown rice,  is expected to become the next weapon in
the battle against high cholesterol,  said Dr.  John Hunnell,  assistant vice-
president,  director  of  research  and  development  of  Riviana  Foods Inc.,
Houston.  He says that brown rice is a source of carbohydrates, Vitamins B and
E, and is sodium-free.

                         ORPHAN DRUGS GET CLOSER LOOK:

   Sometimes  a  disease  only  affects  a  group of under 200,000.  When this
happens, drugs that cure that disease get little attention.  Not any more. The
Pharmaceutical Manufacturers Association, Food and Drug Administration and the
National Organization for Rare Disorders will compile a comprehensive list  of
so-called orphan drugs now in development.

                        DRUG APPROVED FOR HYPERTENSION:

   Pfizer  Inc.  said  Wednesday  the  U.S.  Food  and Drug Administration had
approved Procardia XL for the treatment of angina and hypertension.  Procardia
X  - a calcium channel blocker -has a controlled release formula over 24 hours
and causes minimal side effects.  The drug will be  launched  shortly,  Pfizer
Inc. said.

                          BREAST IMPLANTS CAUSE HARM:

   A new study, published in the Sept. 1 issue of Annals of Internal Medicine,
shows that silicone might escape from gel-filled prostheses,  causing systemic
sclerosis (inflammation and hardening of tissue). Sclerosis remained after the

Health InfoCom Network News                                             Page  3
Volume  2, Number 33                                      September 11, 1989

implants were removed because leakage into  lymph  tissue  had  already  taken
place, the report says.

                        BONE-MASS LINKED TO FRACTURES:

   The  amount of bone mass in the forearm's radius predicts future fractures,
says a new study published  in  the  Sept.  1  issue  of  Annals  of  Internal
Medicine. In a group of more than 500 women, a single measurement of bone mass
in the radius was related to the non-spine fractures. A slight decline in bone
mass could increase fracture risk by 120 percent, the study says.

                        RESEARCHERS MAKING TOUGH TEETH:

   By  borrowing technology from the auto industry,  dental researchers at the
University of Florida are trying to make false teeth, crowns and other ceramic
dental appliances tougher by exposing them to a heat-tempering process used to
make car windshields shatter-resistant.  The technique makes dental  porcelain
disks crack-, chip- and fracture-resistant.

                           FISH KEEPS HEART HEALTHY:

   After studying 852 men in the Dutch town of Zutphen,  Greenland, over a 20-
year period,  scientists conclude that consumption of as little as one or  two
fish  dishes per week might help prevent coronary disease,  says an article in
the September issue of consumer Reports Health Letter.

                          FISH OIL PREVENTS CLOTTING:

   Studies show that high doses of omega-3 fatty acids,  found in  fish  oils,
interfere  with  clotting  by  making blood platelets less sticky.  Thus,  the
platelets don't form clots,  which in coronary arteries  triggers  most  heart
attacks,  says  an  article  in the September issue of Consumer Reports Health
Letter.

Health InfoCom Network News                                             Page  4
Volume  2, Number 33                                      September 11, 1989

===============================================================================
                      Center for Disease Control Reports
===============================================================================

                     Morbidity and Mortality Weekly Report
                          Thursday  September 7, 1989

                                Current Trends
                        Measles -- United States, 1988

    In 1988,  a provisional total of 3411 measles cases was  reported  to  the
Division of Immunization,  Center for Prevention Services,  CDC,  7% less than
the 3652 cases reported during the same period in 1987  (Figure  1)  (1).  The
overall  incidence  rate  for 1988 was 1.4 cases per 100,000 population.  Nine
states reported greater than or equal to 100  cases  and  accounted  for  2802
(82.1%) cases:  California (836),  Pennsylvania (542), New Jersey (402), Texas
(287),  Virginia (239),  Florida (170),  Colorado (117),  Ohio (109),  and New
Hampshire (100). Seven states had incidence rates greater than 2.0 per 100,000
population:   Montana   (10.7),   New  Hampshire  (9.2),   New  Jersey  (5.2),
Pennsylvania (4.5),  Virginia (4.0),  Colorado (3.5),  and  California  (3.0).
Thirty-six  states  and  211  (6.7%)  of  the  nation's 3138 counties reported
measles cases.
    A total of 3176 (93.1%) cases met the standard  clinical  case  definition
for  measles,*  and  1001  (29.3%)  were  serologically  confirmed.  The usual
seasonal pattern was observed with cases peaking during weeks 18-25  (May  and
June).
    Eighty-seven  (2.6%) cases were known to be imported from other countries.
An additional 126 (3.7%) cases were epidemiologically linked to imported cases
within two generations.  Fifty-seven outbreaks (five or more epidemiologically
linked  cases)  were  reported  and  accounted  for  89.3%  of all cases.  Six
outbreaks had greater than 100 cases and accounted for 52.7% of  all  reported
cases.  Most  outbreaks  occurred  among  school-aged  children.  The  largest
outbreak (611 cases) occurred in Los Angeles among unvaccinated preschool-aged
children.
    The incidence rate of measles decreased between 1987 and 1988 for 0-4-, 5-
9-,  and 10-14-year-olds,  and increased in 15-19-  and  20-24-year-olds.  The
highest  incidence  rate  (5.8 per 100,000) occurred in 15-19-year-olds (Table
1).
    Complications were  reported  in  408  (12.0%)  cases.  Otitis  media  was
reported in 183 (5.4%);  diarrhea, in 128 (3.8%); pneumonia, in 93 (2.7%); and
encephalitis,  in four (0.1%).  Three hundred sixty-eight (10.8%) persons were
hospitalized.  Three  measles-attributable deaths were reported (case-fatality
rate: 0.9 deaths per 1000 cases).
    Of the  2179  (63.9%)  patients  for  whom  setting  of  transmission  was
reported,  871  (40.0%) acquired measles in primary or secondary schools;  267
(12.3%), in colleges or universities;  553 (25.4%),  at home;  127 (5.8%),  in
medical settings;  69 (3.2%),  in day care;  and 292 (13.4%),  in a variety of
other settings.
    A total of 1548 (45.4%) patients had been vaccinated on or after the first
birthday (Table 2),  including 729 (21.4%) who were vaccinated at 12-14 months
of  age.  One  thousand  eight  hundred  sixty-three  (54.6%) persons were not
vaccinated on or after the first birthday.  Of these,  vaccination would  have
been  routinely indicated** for 803 (23.5%).  Six hundred twenty-eight (18.4%)
cases occurred in persons for whom vaccine was not  routinely  indicated,  and
432 (12.7%) were unvaccinated for other reasons.

Health InfoCom Network News                                             Page  5
Volume  2, Number 33                                      September 11, 1989

    Of the 3411 reported cases,  1942 occurred among school-aged children.  Of
these,  1339 (68.9%) had been appropriately vaccinated.  Most of  the  vaccine
failures occurred in persons 12-19 years of age (Figure 2).

Reported by: Div of Immunization, Center for Prevention Svcs, CDC.

Editorial  Note:  Since  1983,  the number of reported measles cases increased
annually until 1986,  then decreased in 1987 and slightly in 1988 (Figure  1).
In 1988, the age distribution of cases was similar to those in previous years.
As in previous years,  primarily two types of outbreaks occurred:  those among
highly vaccinated (vaccine coverage greater than 90%) school-aged children and
those among unvaccinated preschool-aged children (2).
    The epidemiology of measles points to two  major  impediments  to  measles
elimination--unvaccinated preschool-aged children, allowing large outbreaks in
inner-city  areas,  and  vaccine failures,  accounting for outbreaks in highly
vaccinated  school-aged  populations.   Therefore,   in  January   1989,   the
Immunization    Practices    Advisory    Committee   (ACIP)   issued   revised
recommendations  (3).   First,  ACIP  lowered  the  age  for  routine  measles
vaccination  in  inner-city areas to as low as 9 months so that children would
be vaccinated before they could be exposed  to  measles,  and  coverage  would
therefore  be  increased.  Second,  ACIP  recommended  that,  for outbreaks in
schools,   previously  vaccinated  persons  in  specific  target   groups   be
revaccinated   in   affected  schools  and  unaffected  schools  at  risk  for
transmission.  The groups targeted for revaccination  are  persons  vaccinated
before  1980 or vaccinated at 12-14 months of age.  The rationale for choosing
the 1980  date  has  been  described  (3).  Data  from  four  recent  outbreak
investigations have shown that persons vaccinated before 1980 are at increased
risk  for measles (Table 3).  This is believed to be due primarily to a higher
rate of failure of initial seroconversion for persons vaccinated  before  that
time.  Although  children  vaccinated  between  12 and 14 months of age are at
higher risk than are children vaccinated at older ages,  only  a  minority  of
children  with  measles  in  most outbreaks have been vaccinated between these
ages (1).
    Implementation of these new outbreak-control recommendations  during  1989
has been expensive because of the large number of outbreaks and cases.  In the
first 26 weeks of 1989,  8553 cases were reported,  a 392% increase  over  the
same  period  in  1988.  More than 90 outbreaks have been reported;  most have
occurred  in  secondary  schools  and  colleges.   Seventy-one  colleges  have
reported  at  least one case of measles.  The largest outbreak has occurred in
Houston, with greater than 1700 cases, primarily among unvaccinated preschool-
aged children. Several states have spent several hundred thousand dollars each
to revaccinate young adults in secondary schools and colleges.
    Because of continued outbreaks among school-aged children,  in  May  1989,
the ACIP decided to recommend a routine two-dose measles vaccination schedule.
The  second  dose will be administered at entry to kindergarten or first grade
(children 4-6 years of age). A two-dose schedule will decrease primary vaccine
failures and thus the number of susceptibles and measles outbreaks in  school-
aged  children.  In  add ition,  outbreak-control measures will be simplified.
Detailed recommendations for this schedule  and  outbreak  control  are  being
formulated  and  will  be  published  in  the  fall of 1989.  Until then,  the
previously published schedules and recommendations  should  be  followed.  The
American  Academy  of Pediatrics has also developed a routine two-dose measles
vaccination schedule,  which recommends that the second dose be given at entry
to middle or junior high school (7).
    The  two-dose schedule will not affect outbreaks in inner-city areas among

Health InfoCom Network News                                             Page  6
Volume  2, Number 33                                      September 11, 1989

unvaccinated preschool-aged children.  Prevention of such  outbreaks  requires
intensive  efforts directed at increasing age-appropriate immunization levels,
which are being initiated by CDC and state and local health departments. These
include activities in  service  delivery,  assessment,  information/education,
operational  research  and  surveillance.  The two-dose schedule and intensive
efforts to raise age-appropriate immunization  levels  should  facilitate  the
goal of measles elimination in the United States.

References

1. CDC. Measles--United States, 1987. MMWR 1988;37:527-31.

2.  Markowitz LE, Preblud SR, Orenstein WA, et al. Patterns of transmission in
measles outbreaks in the United States,  1986-1987.  N Engl J Med 1989;320:75-
81.

3. ACIP. Measles prevention: supplementary statement. MMWR 1989;38:11-4.

4. Hutchins SS, Markowitz LE, Mead P, et al. A selective measles revaccination
policy   during   a  school-based  measles  outbreak  (Abstract).   In:   CDC.
Proceedings of the 1988 EIS Conference.  Atlanta:  US Department of Health and
Human Services, Public Health Service, 1988:29.

5.  Mast EE,  Berg JL,  Hanrahan LP, Davis JP.  Measles in a highly vaccinated
population:  possible causes of measles vaccine failure (Abstract).  In:  CDC.
Proceedings of the 1989 EIS Conference.  Atlanta:  US Department of Health and
Human Services, Public Health Service, 1989:70.

6. Rullan JV, Pozo F, Gamble WB Jr, Jackson K, Parker RL.  Measles in a highly
vaccinated South Carolina school population (Abstract).  In: CDC.  Proceedings
of the 1987 EIS  Conference.  Atlanta:  US  Department  of  Health  and  Human
Services, Public Health Service, 1987:24.

7.  American  Academy  of  Pediatrics.  Measles:  reassessment  of the current
immunization policy. AAP News 1989;(July):6-7.

*Fever greater than or equal to 101 F (greater than or equal to  38.3  C),  if
measured;  generalized  rash  lasting greater than or equal to 3 days;  and at
least one of the following: cough, coryza, or conjunctivitis.

**Cases in persons  who  were  eligible  for  vaccination  but  who  were  not
vaccinated.

Health InfoCom Network News                                             Page  7
Volume  2, Number 33                                      September 11, 1989

                    Progress in Chronic Disease Prevention
       Surgeon General's Workshop on Health Promotion and Aging: Summary
                Recommendations of the Medication Working Group

    The  "Surgeon  General's  Workshop  on  Health Promotion and Aging" met in
Washington,  D.C.,  on  March  20-23,  1988.  This  workshop  provided  health
professionals  with  recommendations  and  proposals for health promotion that
address the needs of the elderly.  The recommendations of the Alcohol  Working
Group have been summarized (1). Following is a summary of recommendations from
the Medication Working Group.

            SUMMARY  RECOMMENDATIONS OF THE MEDICATION WORKING GROUP

                            Education and Training

o More training and continuing medical education courses  should  be  provided
    that emphasize the resources available to the prescriber, understanding of
    age-related   physiologic   metabolic   changes,   nonjudgmental  patient-
    counseling skills, and interdisciplinary communication skills.

o Social service providers,  home caregivers,  family members of older adults,
    and  older  adults should be trained in medication management and educated
    about the potential for adverse medication reactions.

o The role of pharmacists in  management  of  and  education  about  geriatric
    medications  should be expanded,  and sites for prescribing information in
    all practice settings should be identified.

                                    Service

o Reimbursement for pharmacy services for the elderly should be independent of
    dispensation or cost of the product.

o Reimbursement patterns should encourage better access to  medical  care  for
    persons needing complex medication regimens and for isolated patients.

o  Access  to  medicines  and  pharmaceutical services should be included as a
    basic part of health-care programs for  the  elderly  and  should  include
    access to medicines for the geographically isolated and mobility-impaired.

o  Community-based  programs  should  strengthen  efforts to ensure that older
    Americans have the information necessary to participate with their health-
    care providers in medication management.

                                   Research

o Cross-sectional and longitudinal  studies  and  other  pharmacoepidemiologic
    research  should  emphasize  nonlethal  side  effects,   efficacy,  risks,
    compliance, and cost-effectiveness of medications.

o National data sets  should  be  studied  further  to  assess  medication-use
    patterns among older adults.

o  Studies  should focus on cost-effective means of educating the consumer and
    the home caregiver on proper use of medications  and  monitoring  of  side

Health InfoCom Network News                                             Page  8
Volume  2, Number 33                                      September 11, 1989

    effects  and  on  the  standardization  of  medication  profile  and  drug
    interaction information.

                                    Policy

o  The  federal  government  should  implement  quickly  the  recently  passed
    medication  provisions  of  the Medicare Catastrophic Coverage Act of 1988
    (100 PL 360; 1988 H.R. 2470).

o Regulatory agencies should explore  fraud  and  quackery  by  reviewing  the
    marketing  of  certain  drugs,  vitamins,  food  stuffs,  and  nutritional
    supplements used as medications.

o The Food and Drug  Administration  (FDA)  should  complete  development  and
    implementation  of  proposed  guidelines for drugs for use in the elderly,
    especially elderly subgroups at risk,  and should emphasize not  excluding
    persons from participating in clinical trials on the basis of age alone.

o  Drug  labeling should be enforced and should emphasize patient education by
    including specific instructions for the elderly.

Reported by: Office of the Surgeon General, Public Health Svc.  Cardiovascular
Health Br,  Div of Chronic Disease Control and Community Intervention,  Center
for Chronic Disease Prevention and Health Promotion, CDC.

Editorial  Note:  Most  (60%)  adverse  reactions from drugs are pharmacologic
(2,3),  and many of these may be preventable with  more  careful  prescribing,
monitoring,  and  patient  education.  Elderly patients have a higher risk for
developing adverse drug reactions than do persons in  the  general  population
(4,5);  use  of  multiple  drugs  may be the strongest of several factors that
predispose older persons to this excess risk. Thus, one important strategy for
preventing adverse drug reactions among elderly persons is to limit the number
of drugs used.  This approach can reduce side effects, the possibility of drug
interactions, and noncompliance (6).  Furthermore, noncompliance appears to be
associated more with the number of prescribed drugs taken than with increasing
patient age (7).
    Understanding  of  drug  reactions  in the elderly is based on multicenter
collaborative drug surveillance programs,  voluntary  reporting  to  the  FDA,
cohort studies, control phase of intervention demonstrations, institutional or
population-specific  prevalence  surveys,  and  computerized record linkage of
secondary data sets. FDA data now indicate an overall rate of 8.5 adverse drug
reaction reports per 100,000 population;  the rate among persons aged  greater
than or equal to 65 years is 16.0, nearly double this rate (5).
    Antihypertensive  diuretics  provide  an  important  illustration  of  the
current problems  and  the  potential  solutions  in  the  area  of  geriatric
medications.  When  FDA data from 1968 through 1982 were tabulated to identify
medications  associated  with  untoward  effects  in   older   patients   (4),
antihypertensive  diuretics  ranked  fifth among the generic drug classes with
the  highest  reported  number  of  adverse   drug   reactions.   Studies   on
hypertension  in  the  elderly  have  demonstrated the importance of attentive
monitoring during treatment (8,9).  Such monitoring is important because these
medications  are  so frequently implicated in adverse drug reactions among the
elderly (7).
    A major recurring theme in the recommendations of  the  Surgeon  General's
Workshop  is  education  of  health professionals,  home caregivers and family

Health InfoCom Network News                                             Page  9
Volume  2, Number 33                                      September 11, 1989

members, and the elderly patients themselves. Implementing the recommendations
of the Medication Working Group should help reduce the number of adverse  drug
reactions and increase medication compliance among the elderly.

References

1.  CDC.  Surgeon  General's  Workshop on Health Promotion and Aging:  summary
recommendations of the Alcohol Working Group. MMWR 1989;38:385-8.

2.  Burnum JF.  Preventability of adverse drug reactions (Letter).  Ann Intern
Med 1976;85:80-1.
--- end part 1 of 2 cut here ---